Benjamin Caulier

Benjamin Caulier is a Senior Scientist and Discovery Project Leader at Nykode Therapeutics, specializing in cancer vaccines and immunotherapy since October 2023. Prior to this role, Benjamin served as a Postdoctoral Research Fellow at Oslo universitetssykehus, focusing on target discovery and development of Chimeric Antigen Receptor (CAR) therapy, where responsibilities included project management, supervision of studies, and conducting various assays. Benjamin also held a Postdoctoral Research Fellow position at CHU de Grenoble, where efforts were concentrated on developing therapeutic virus-like particles for Acute Myeloid Leukemia treatment. Benjamin began research experience as a PhD student at CNRS, developing non-integrative protein vectors for clinical-grade induced pluripotent stem cells. Educational qualifications include a PhD in Biotechnology from Université Grenoble Alpes and a Master's degree in Immunology and Microbiology from the same institution.